Literature DB >> 23373998

Distant metastasis in triple-negative breast cancer.

L M Tseng1, N C Hsu, S C Chen, Y S Lu, C H Lin, D Y Chang, H Li, Y C Lin, H K Chang, T C Chao, F Ouyang, M F Hou.   

Abstract

Triple-negative breast cancer (TNBC) relapses more frequently than hormone receptor-positive subtypes and is often associated with poor outcomes. This retrospective study reviewed the pattern of distant metastasis with regard to survival in patients with TNBC. A total of 205 TNBC patients were analyzed. TNBC patients with lung metastases had the longest median post-metastatic OS (with 95% confidence interval) of 16.6 (10.3-22.9) months, followed by the bone, 16.3 (11.7-20.8) months, the liver, 8.9 (3.5-14.4) months, the pleura, 7.5 (2.8-12.3) months, and the brain, 4.3 (0.6-8.0) months. Kaplan-Meier plots indicated that TNBC patients with metastatic spread to brain, liver, and pleural had poorer post-metastatic OS rate than patients with lung metastases (p = 0.001, 0.004, and 0.029, respectively). Moreover, brain and liver metastases correlated significantly with poorer post-metastatic OS as compared to bone metastasis (p = 0.004 and 0.011, respectively). Route of first metastasis correlated significantly with survival of TNBC patients with brain metastases being the poorest survival indicator, followed by metastases to liver, pleura, bone, and lung.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23373998     DOI: 10.4149/neo_2013_038

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  41 in total

1.  Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5.

Authors:  Chengshuai Si; Qiao Yu; Yufeng Yao
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

Review 2.  Brain metastasis in breast cancer: a comprehensive literature review.

Authors:  Rezvan Rostami; Shivam Mittal; Pooya Rostami; Fattaneh Tavassoli; Bahman Jabbari
Journal:  J Neurooncol       Date:  2016-02-24       Impact factor: 4.130

3.  Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection.

Authors:  Sai An; Karthik Tiruthani; Ying Wang; Ligeng Xu; Mengying Hu; Jingjing Li; Wantong Song; Hongnan Jiang; Jirui Sun; Rihe Liu; Leaf Huang
Journal:  Small       Date:  2019-01-28       Impact factor: 13.281

4.  A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.

Authors:  Po-Shun Wang; Cheng-Han Chou; Cheng-Han Lin; Yun-Chin Yao; Hui-Chuan Cheng; Hao-Yi Li; Yu-Chung Chuang; Chia-Ning Yang; Luo-Ping Ger; Yu-Chia Chen; Forn-Chia Lin; Tang-Long Shen; Michael Hsiao; Pei-Jung Lu
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

5.  Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells.

Authors:  Chintan H Kapadia; Stephen A Ioele; Emily S Day
Journal:  J Biomed Mater Res A       Date:  2019-11-26       Impact factor: 4.396

6.  Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.

Authors:  Erica T Goddard; Ryan C Hill; Alexander Barrett; Courtney Betts; Qiuchen Guo; Ori Maller; Virginia F Borges; Kirk C Hansen; Pepper Schedin
Journal:  Int J Biochem Cell Biol       Date:  2016-10-24       Impact factor: 5.085

7.  Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating Cells.

Authors:  Daisuke Yamashita; Mutsuko Minata; Ahmed N Ibrahim; Shinobu Yamaguchi; Vito Coviello; Joshua D Bernstock; Shuko Harada; Richard A Cerione; Bakhos A Tannous; Concettina La Motta; Ichiro Nakano
Journal:  Mol Cancer Ther       Date:  2020-03-03       Impact factor: 6.261

8.  Isolated thoracic perfusion in lung metastases from breast cancer: a retrospective observational study.

Authors:  Stefano Guadagni; Karl Aigner; Odisseas Zoras; Francesco Masedu; Giammaria Fiorentini; Enrico Ricevuto; Marcello Deraco; Marco Clementi
Journal:  Updates Surg       Date:  2018-12-12

9.  Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer.

Authors:  Mevlude Inanc; Metin Ozkan; Halit Karaca; Veli Berk; Oktay Bozkurt; Ayse Ocak Duran; Ersin Ozaslan; Hulya Akgun; Fatos Tekelioglu; Ferhan Elmali
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

10.  Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer.

Authors:  Johannes F Fahrmann; Jody Vykoukal; Alia Fleury; Satyendra Tripathi; Jennifer B Dennison; Eunice Murage; Peng Wang; Chuan-Yih Yu; Michela Capello; Chad J Creighton; Kim-Anh Do; James P Long; Ehsan Irajizad; Christine Peterson; Hiroyuki Katayama; Mary L Disis; Banu Arun; Samir Hanash
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.